Maker of Hepatitis B antiviral raises $9M
There’s been a lot of hype around new Hep C drugs (cough, Gilead, cough), but less attention’s paid to Hepatitis B, a stunningly prevalent version of the virus that can lead to cirrhosis and liver cancer. Novira Therapeutics just raised $9 million in debt from 10 investors, according to a regulatory filing. The startup last year […]